These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38752902)

  • 41. Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.
    Kobayashi Y; Lønborg J; Jong A; Nishi T; De Bruyne B; Høfsten DE; Kelbæk H; Layland J; Nam CW; Pijls NHJ; Tonino PAL; Warnøe J; Oldroyd KG; Berry C; Engstrøm T; Fearon WF;
    J Am Coll Cardiol; 2018 Sep; 72(12):1321-1329. PubMed ID: 30213322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of percutaneous coronary intervention on coronary blood flow at rest in myocardial sites remote from the intervention site in patients with stable angina pectoris.
    Manfrini O; Slucca M; Pizzi C; Colombo A; Viecca M; Bugiardini R
    Am J Cardiol; 2008 Mar; 101(6):776-9. PubMed ID: 18328839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of angina resolution after percutaneous coronary intervention in stable coronary artery disease.
    Verreault-Julien L; Bhatt DL; Jung RG; Di Santo P; Simard T; Avram R; Hibbert B
    Coron Artery Dis; 2022 Mar; 33(2):98-104. PubMed ID: 34148973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics.
    Ferrari R; Ford I; Fox K; Marzilli M; Tendera M; Widimský P; Challeton JP; Danchin N
    Am Heart J; 2019 Apr; 210():98-107. PubMed ID: 30771737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blinded Physiological Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention: The DEFINE PCI Study.
    Jeremias A; Davies JE; Maehara A; Matsumura M; Schneider J; Tang K; Talwar S; Marques K; Shammas NW; Gruberg L; Seto A; Samady H; Sharp A; Ali ZA; Mintz G; Patel M; Stone GW
    JACC Cardiovasc Interv; 2019 Oct; 12(20):1991-2001. PubMed ID: 31648761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retrospective Comparison of Long-Term Clinical Outcomes Between Percutaneous Coronary Intervention and Medical Therapy in Stable Coronary Artery Disease With Gray Zone Fractional Flow Reserve　- COMFORTABLE Retrospective Study.
    Kubo T; Takahata M; Terada K; Mori K; Arita Y; Ino Y; Matsuo Y; Kitabata H; Shiono Y; Shimamura K; Kameyama T; Emori H; Katayama Y; Tanimoto T; Akasaka T
    Circ J; 2018 Nov; 82(12):3044-3051. PubMed ID: 30318503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina.
    Zhang Z; Kolm P; Boden WE; Hartigan PM; Maron DJ; Spertus JA; O'Rourke RA; Shaw LJ; Sedlis SP; Mancini GB; Berman DS; Dada M; Teo KK; Weintraub WS
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):172-82. PubMed ID: 21304091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
    Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of percutaneous coronary intervention on dyspnea in stable coronary artery disease.
    Wester M; Koll F; Luedde M; Langer C; Resch M; Luchner A; Müller K; Zeman F; Koller M; Maier LS; Sossalla S
    Clin Res Cardiol; 2023 Sep; 112(9):1194-1203. PubMed ID: 36100700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of Percutaneous Revascularization on Exercise Hemodynamics in Patients With Stable Coronary Disease.
    Cook CM; Ahmad Y; Howard JP; Shun-Shin MJ; Sethi A; Clesham GJ; Tang KH; Nijjer SS; Kelly PA; Davies JR; Malik IS; Kaprielian R; Mikhail G; Petraco R; Al-Janabi F; Karamasis GV; Mohdnazri S; Gamma R; Al-Lamee R; Keeble TR; Mayet J; Sen S; Francis DP; Davies JE
    J Am Coll Cardiol; 2018 Aug; 72(9):970-983. PubMed ID: 30139442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reclassification of Treatment Strategy With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A Substudy From the iFR-SWEDEHEART Trial.
    Andell P; Berntorp K; Christiansen EH; Gudmundsdottir IJ; Sandhall L; Venetsanos D; Erlinge D; Fröbert O; Koul S; Reitan C; Götberg M
    JACC Cardiovasc Interv; 2018 Oct; 11(20):2084-2094. PubMed ID: 30336812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The challenges of a randomised placebo-controlled trial of CTO PCI vs. placebo with optimal medical therapy: The ORBITA-CTO pilot study design and protocol.
    Khan S; Fawaz S; Simpson R; Robertson C; Kelly P; Mohdnazri S; Tang K; Cook CM; Gallagher S; O'Kane P; Spratt J; Brilakis ES; Karamasis GV; Al-Lamee R; Keeble TR; Davies JR
    Front Cardiovasc Med; 2023; 10():1172763. PubMed ID: 37206100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve.
    Xaplanteris P; Fournier S; Pijls NHJ; Fearon WF; Barbato E; Tonino PAL; Engstrøm T; Kääb S; Dambrink JH; Rioufol G; Toth GG; Piroth Z; Witt N; Fröbert O; Kala P; Linke A; Jagic N; Mates M; Mavromatis K; Samady H; Irimpen A; Oldroyd K; Campo G; Rothenbühler M; Jüni P; De Bruyne B;
    N Engl J Med; 2018 Jul; 379(3):250-259. PubMed ID: 29785878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term clinical outcome after fractional flow reserve- versus angio-guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass grafts.
    Di Serafino L; De Bruyne B; Mangiacapra F; Bartunek J; Agostoni P; Vanderheyden M; Scognamiglio G; Heyndrickx GR; Wijns W; Barbato E
    Am Heart J; 2013 Jul; 166(1):110-8. PubMed ID: 23816029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation).
    Fearon WF; Nishi T; De Bruyne B; Boothroyd DB; Barbato E; Tonino P; Jüni P; Pijls NHJ; Hlatky MA;
    Circulation; 2018 Jan; 137(5):480-487. PubMed ID: 29097450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study.
    Biscaglia S; Tebaldi M; Brugaletta S; Cerrato E; Erriquez A; Passarini G; Ielasi A; Spitaleri G; Di Girolamo D; Mezzapelle G; Geraci S; Manfrini M; Pavasini R; Barbato E; Campo G
    JACC Cardiovasc Interv; 2019 Oct; 12(20):2079-2088. PubMed ID: 31563688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic Value of Measuring Fractional Flow Reserve After Percutaneous Coronary Intervention in Patients With Complex Coronary Artery Disease: Insights From the FAME 3 Trial.
    Piroth Z; Otsuki H; Zimmermann FM; Ferenci T; Keulards DCJ; Yeung AC; Pijls NHJ; De Bruyne B; Fearon WF
    Circ Cardiovasc Interv; 2022 Nov; 15(11):884-891. PubMed ID: 36121706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of information presentation on beliefs about the benefits of elective percutaneous coronary intervention.
    Rothberg MB; Scherer L; Kashef MA; Coylewright M; Ting HH; Hu B; Zikmund-Fisher BJ
    JAMA Intern Med; 2014 Oct; 174(10):1623-9. PubMed ID: 25156687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
    Werner GS; Martin-Yuste V; Hildick-Smith D; Boudou N; Sianos G; Gelev V; Rumoroso JR; Erglis A; Christiansen EH; Escaned J; di Mario C; Hovasse T; Teruel L; Bufe A; Lauer B; Bogaerts K; Goicolea J; Spratt JC; Gershlick AH; Galassi AR; Louvard Y;
    Eur Heart J; 2018 Jul; 39(26):2484-2493. PubMed ID: 29722796
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.